Skip to main content
Glama
yesc97

biopharma-catalyst-mcp

by yesc97
OverviewSchemaSourceRelated ServersDiscussionsAdmin
TypeScript
Remote

Related Servers

Alternatives to biopharma-catalyst-mcp

No user-submitted related servers found.

    Related Servers

    • cti-mcp

      hjsh200219
      F
      license
      A
      quality
      D
      maintenance
      Enables to analyze Korean pharma/biotech stocks using clinical trial data from ClinicalTrials.gov and market data from Naver Finance, providing 100-point scoring, decision labels, and technical indicators.
      10
      -

    • Medical Research MCP Suite

      ezhou89
      A
      license
      B
      quality
      D
      maintenance
      Enables comprehensive medical research by querying and analyzing data across ClinicalTrials.gov, PubMed, and FDA databases with AI-enhanced cross-database insights, risk assessments, and competitive intelligence.
      13
      11
      MIT

    • zetesis

      reutavidan
      A
      license
      A
      quality
      B
      maintenance
      Enables scientific due diligence by grading claims against public literature, clinical trials, and filings, with explicit citations and optional attestation.
      4
      MIT

    • Investment Intelligence MCP

      mjtahir02-alt
      F
      license
      Not graded
      quality
      B
      maintenance
      Enables aggregated investment research by combining data from Yahoo/SEC EDGAR, Finnhub, and GDELT with analysis modules for price momentum, news signals, and estimate revisions.
      -

    • Catalyst Edge MCP

      rm0nroe
      A
      license
      A
      quality
      A
      maintenance
      Provides read-only tools to retrieve source-linked catalyst evidence dossiers for public-company tickers, including deterministic catalyst scores and paged source records.
      2
      MIT
    Deploy Server
    One endpoint for every MCP toolRayrun runs every MCP server behind one URL and holds the credentials. Each call is decided per client, tool, and argument, then recorded.ray.runAd

    TDQS

    A3.9/5.0

    Scored across 10 tools

    Disambiguation5/5

    Each tool targets a distinct aspect of biopharma analysis—FDA activity, clinical trials, insider transactions, SEC filings, market data, short interest, XBRL facts, PubMed literature, and a high-level aggregator. There is no overlap; even the audit_catalyst synthesizes data from others rather than duplicating.

    Naming Consistency5/5

    Tool names follow a consistent verb_noun pattern with underscores: 'get_*' for data retrieval, 'search_*' for database queries, and 'audit_catalyst' for the aggregator. The verb choice accurately reflects the action type, and all names are clear and predictable.

    Tool Count5/5

    Ten tools is within the ideal 3-15 range for a domain-specific MCP server. Each tool covers a necessary data source or analytical function, and none feel redundant or extraneous.

    Completeness5/5

    The tool set covers the full lifecycle of biopharma catalyst analysis: FDA actions, clinical trials, insider trading, financials (XBRL and SEC filings), short interest, market data, and literature. The audit_catalyst aggregates these into a verdict, leaving no obvious gaps for the stated purpose.

    Maintenance

    ActivityInactive
    ResponsivenessNo issues

    Resources